title: Bilateral infusion pump implants as therapy for refractory corneal ulcers in a patient with CREST syndrome: an interdisciplinary approach.
abstract: Internal infusion pumps are implantable and programmable systems that have been widely used for years in the management of chronic pain. During the past few years, these devices have had an increasingly prominent role given the possibility of insulin infusions in patients with diabetes mellitus because they provide patients with higher autonomy in the management of their disease, despite the fact that they are expensive systems and require surgery for implantation. These features make internal infusion pumps a suitable therapeutic option for those patients who need to use artificial tears continuously because of severe dry eyes. We report a case of severe eye pain due to xerophthalmia in a patient with CREST (calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) syndrome who was treated with an implanted pump reservoir.
authors.affiliation: Departments of Anesthesia, Critical Care, and PainManagement, University General Hospital, Valencia, Spain.
authors.forename: José
authors.initials: J
authors.lastname: De Andrés
authors.forename: Salvador
authors.initials: S
authors.lastname: García-Delpech
authors.forename: Vicente Luis Villanueva
authors.initials: VL
authors.lastname: Pérez
authors.forename: Manuel
authors.initials: M
authors.lastname: Díaz-Llopis
authors.forename: Patricia
authors.initials: P
authors.lastname: Udaondo
authors.forename: María Teresa Serrano
authors.initials: MT
authors.lastname: Sánchez
authors.forename: David
authors.initials: D
authors.lastname: Salom
mesh_terms: D017675:CREST Syndrome / Q000150:complications*; D003320:Corneal Ulcer / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D015918:Infusion Pumps, Implantable; D008875:Middle Aged; D010348:Patient Care Team / Q000458:organization & administration; D012008:Recurrence; D012859:Sjogren's Syndrome / Q000188:drug therapy / Q000209:etiology; D012965:Sodium Chloride / Q000008:administration & dosage*; D040521:Subcutaneous Tissue; D014985:Xerophthalmia / Q000188:drug therapy / Q000209:etiology
chemical_list: D012965:Sodium Chloride